Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bone Biologics Corp (NQ: BBLG )

1.580 +0.190 (+13.67%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 238,476
Open 1.360
Bid (Size) 1.500 (1)
Ask (Size) 1.550 (4)
Prev. Close 1.390
Today's Range 1.360 - 1.620
52wk Range 1.000 - 10.56
Shares Outstanding 1,801,427
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BBLG Stock Earnings: Bone Biologics Beats EPS for Q2 2024
BBLG stock results show that Bone Biologics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We have all of the biggest pre-market stock movers that traders need to know about on Friday with the latest news breakdowns! 
Via InvestorPlace

Performance

YTD
-61.84%
-61.84%
1 Month
+31.68%
+31.68%
3 Month
+3.95%
+3.95%
6 Month
-49.84%
-49.84%
1 Year
-74.67%
-74.67%

More News

Read More
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
From Bone Biologics Corporation
Via Business Wire
Nasdaq Surges 1%; Meta Posts Upbeat Earnings
Via Benzinga
Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nasdaq Down 2%; Alphabet Posts Upbeat Earnings
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
From Bone Biologics Corporation
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
From Virtual Investor Conferences
Via GlobeNewswire
Bone Biologics Executives to be Interviewed in a “CEO Chat” by Zacks Small-Cap Research Analyst on June 20th
From Virtual Investor Conferences
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
BBLG Stock Earnings: Bone Biologics Beats EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Bone Biologics Announces Closing of $2.0 Million Public Offering
From Bone Biologics Corporation
Via Business Wire
Bone Biologics Announces Pricing of $2.0 Million Public Offering
From Bone Biologics Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why BioVie Shares Are Trading Lower By Around 42%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.